| abstract |
A method and composition for the treatment of humans infected with HIV thatnincludes administration of an HIV treatment amount of an enantiomericallynpure β-D-dioxolanyl purine nucleoside of formula (I), wherein R is OH, Cl,nNH 2 , or H, or a pharmaceutically acceptable salt or derivative of thencompound, optionally in a pharmaceutically acceptable carrier or diluent. |